News for Nurix Therapeutics, Inc. (NRIX)

Air India Boeing jet crashes shortly after takeoff. Nvidia and Samsung to take minority stakes in robotics startup Skild AI - report. Chime Financial prices IPO at $27, above expected price.

**media[638992]**

**media[628728]**

Nurix's lead BTK degrader, bexobrutideg, demonstrates exceptional efficiency, with a single molecule degrading approximately 10,000 copies of BTK per hour BR

On Wednesday, April 23, 2025, Cathie Wood of Ark Invest purchased more stock of AMD and Nvidia amid looming US chip curbs against China.

Collaboration partner, Gilead Sciences, to begin Phase 1 single ascending dose (SAD) and multiple ascending dose (MAD) study in healthy volunteers in Q2 2025

**media[597931]**

Nurix Therapeutics (NRIX) granted inducement awards to 16 new employees as part of their 2024 Equity Inducement Plan. The awards comprise stock options

**media[592903]**

Nurix Therapeutics (NRIX) delivered earnings and revenue surprises of 6.94% and 26.41%, respectively, for the quarter ended February 2025. Do the numbers hold clues to what lies ahead for the stock?

**media[589629]**

Summary: Nurix Therapeutics (NRIX) stocks surge following a new licensing agreement with Sanofi.The collaborative venture focuses on an undisclosed molecule rel

Nurix Therapeutics (NRIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

**media[583680]**

**media[576531]**

Nurix Therapeutics Inc (NRIX), a clinical-stage biopharmaceutical company, announced on March 17, 2025, that the U.S. Food and Drug Administration (FDA) has gra

**media[568256]**

SAN FRANCISCO, March 14, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. ( NRIX), a clinical-stage biopharmaceutical company focused on the discovery, devel

Dr. Baynes has been a member of Nurix's Medical Advisory Board since 2023 SAN FRANCISCO, March 13, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. ( NRI